I
ABBV icon

IberiaBank’s AbbVie ABBV Stock Holding History

IberiaBank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.6M Buy
16,252
+4,633
+40% +$408K 0.19% 108
2020
Q1 		$885K Buy
11,619
+6,857
+144% +$584K 0.12% 119
2019
Q4 		$422K Sell
4,762
-516
-10% -$42.8K 0.04% 178
2019
Q3 		$400K Sell
5,278
-2,699
-34% -$185K 0.05% 178
2019
Q2 		$580K Sell
7,977
-13,495
-63% -$1.06M 0.06% 158
2019
Q1 		$1.73M Sell
21,472
-28,929
-57% -$2.37M 0.2% 105
2018
Q4 		$4.65M Sell
50,401
-3,021
-6% -$266K 0.6% 56
2018
Q3 		$5.05M Sell
53,422
-9,171
-15% -$870K 0.63% 49
2018
Q2 		$5.8M Sell
62,593
-1,818
-3% -$178K 1.01% 23
2018
Q1 		$6.1M Sell
64,411
-13,405
-17% -$1.47M 1.21% 16
2017
Q4 		$7.53M Sell
77,816
-3,026
-4% -$285K 1.18% 24
2017
Q3 		$7.18M Sell
80,842
-791
-1% -$60.2K 1.19% 24
2017
Q2 		$5.92M Buy
81,633
+934
+1% +$62.8K 1.76% 13
2017
Q1 		$5.26M Sell
80,699
-3,703
-4% -$233K 1.66% 15
2016
Q4 		$5.29M Buy
84,402
+7,216
+9% +$440K 1.94% 13
2016
Q3 		$4.87M Buy
77,186
+1,140
+1% +$73.8K 2.07% 15
2016
Q2 		$4.71M Buy
76,046
+2,456
+3% +$150K 2.07% 10
2016
Q1 		$4.2M Sell
73,590
-3,673
-5% -$205K 1.98% 17
2015
Q4 		$4.58M Buy
77,263
+12,807
+20% +$738K 2.06% 7
2015
Q3 		$3.51M Sell
64,456
-3,124
-5% -$203K 1.8% 21
2015
Q2 		$4.54M Buy
67,580
+875
+1% +$57.1K 2.03% 4
2015
Q1 		$3.9M Buy
66,705
+14,114
+27% +$853K 1.75% 9
2014
Q4 		$3.44M Sell
52,591
-3,494
-6% -$220K 1.88% 6
2014
Q3 		$3.24M Buy
56,085
+4,157
+8% +$231K 1.82% 8
2014
Q2 		$2.93M Sell
51,928
-143
-0.3% -$7.5K 1.64% 12
2014
Q1 		$2.68M Buy
52,071
+90
+0.2% +$4.55K 1.65% 14
2013
Q4 		$2.75M Sell
51,981
-3,832
-7% -$188K 1.79% 7
2013
Q3 		$2.5M Buy
55,813
+7,750
+16% +$344K 1.64% 13
2013
Q2 		$1.99M Buy
+48,063
New +$2.1M 1.5% 17

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IberiaBank's ABBV Position: Q2 2020 in Review

IberiaBank increased its AbbVie (ABBV) stake by 40% in Q2 2020, buying an estimated $408K and bringing the position to 16,252 shares worth $1.6M. The position accounts for 0.19% of the portfolio, ranked #108.

IberiaBank first reported a position in ABBV in Q2 2013 and has held it in 29 quarters since. The position peaked at $7.53M in Q4 2017. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • IberiaBank held 16,252 shares of AbbVie worth $1.6M as of Q2 2020.
  • IberiaBank bought 4,633 AbbVie shares in Q2 2020, an estimated $408K.
  • AbbVie made up 0.19% of IberiaBank's portfolio in Q2 2020, its #108 holding.
  • IberiaBank first reported a position in AbbVie in Q2 2013 and has held it in 29 quarters since.
  • IberiaBank's AbbVie position peaked at $7.53M in Q4 2017.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on IberiaBank's 13F filing for Q2 2020, filed 29 Jul 2020.